Table 2 Treatment characteristics
Range | IQR | ||
|---|---|---|---|
Microsphere type | |||
Glass, n (%) | 21 (87.5) | ||
Resin, n (%) | 3 (12.5) | ||
HPS, % | 9,12 | 3.3–19 | 5.26–11.65 |
Target volume, mL | 206.9 | 25–700 | 90–243.6 |
Administered activity, GBq | 1.39 | 0.19–5.8 | 0.545–1.615 |
Theoretical tumor dose, Gy | 306.3 | 250–500 | 300–300 |
Confirmed tumor dose (aAD) Gy | 352 | 127.4–1171 | 168.9–462.7 |
Maximum confirmed dose, Gy | 1216 | 439.1–2767 | 779.8–1378 |
Min dose in 30% of tumor volume | 398.9 | 158.4–1295 | 183.1–523.5 |
Min dose in 50% of tumor volume | 303.5 | 97.4–1138 | 138.5–384.2 |
Min dose in 70% of tumor volume | 205.9 | 43.5–1011 | 107.9–303.9 |
Healthy liver dose | 11.64 | 0.77–39.19 | 4.15–15.8 |